|
[1] 中华医学会肝病学会.慢性乙型肝炎防治指南[J].临床肝胆病杂志, 2006, 22 (1) ∶3-15.
|
|
[1] 中华医学会肝病学会.慢性乙型肝炎防治指南[J].临床肝胆病杂志, 2006, 22 (1) ∶3-15.
|
|
[2]刘刚, 阿德福韦酯基础与临床研究[J].中西医结合肝病杂志, 2006, 16 (5) ∶303-305.
|
|
[2]刘刚, 阿德福韦酯基础与临床研究[J].中西医结合肝病杂志, 2006, 16 (5) ∶303-305.
|
|
[3]Cooksley H, Chokshi S, Wedemeyer H, et al.Hepattis B virus-spe-cific T-cell reactivity during Adefovir dipivotil (ADV) treatment:A multicentre, controlled study[J].J Hepatol, 2002, 36suppl1∶7.
|
|
[3]Cooksley H, Chokshi S, Wedemeyer H, et al.Hepattis B virus-spe-cific T-cell reactivity during Adefovir dipivotil (ADV) treatment:A multicentre, controlled study[J].J Hepatol, 2002, 36suppl1∶7.
|
|
[4]冯萍, 齐钧, 王怡, 等.阿德福韦对HBeAg阳性慢性乙型肝炎患者Th1和Th2相关细胞因子的影响[J].临床肝胆病杂志, 2008, 24 (1) ∶24-25.
|
|
[4]冯萍, 齐钧, 王怡, 等.阿德福韦对HBeAg阳性慢性乙型肝炎患者Th1和Th2相关细胞因子的影响[J].临床肝胆病杂志, 2008, 24 (1) ∶24-25.
|
|
[5]黄小俊, 王鲁文, 龚作炯.阿德福韦酯对慢性乙型肝患者外周IFN-r和IL-18的影响[J].中西结合肝病学杂志, 2007, 17 (6) ∶333—332.
|
|
[5]黄小俊, 王鲁文, 龚作炯.阿德福韦酯对慢性乙型肝患者外周IFN-r和IL-18的影响[J].中西结合肝病学杂志, 2007, 17 (6) ∶333—332.
|
|
[6]钱海清.叶下珠联合阿德福韦酯治疗慢性乙型肝炎42例[J].中西医结合肝病杂志, 2008, 18 (2) ∶15.
|
|
[6]钱海清.叶下珠联合阿德福韦酯治疗慢性乙型肝炎42例[J].中西医结合肝病杂志, 2008, 18 (2) ∶15.
|
|
[7]胡肖兵, 高洪波, 李粤平, 等.阿德福韦酯联合安络化纤丸抗纤维化疗效及组织学变化观察[J].中西医结合肝病杂志, 2008, 18 (2) ∶80-82.
|
|
[7]胡肖兵, 高洪波, 李粤平, 等.阿德福韦酯联合安络化纤丸抗纤维化疗效及组织学变化观察[J].中西医结合肝病杂志, 2008, 18 (2) ∶80-82.
|
|
[8]Lai CL, Shouval D, LOK AS, et al.Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B[J].N Engl J Med, 2006, 354∶1011-1020.
|
|
[8]Lai CL, Shouval D, LOK AS, et al.Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B[J].N Engl J Med, 2006, 354∶1011-1020.
|
|
[9]谢冬英, 林炳亮, 徐启桓, 等.阿德福韦酯治疗e抗原阳性慢性乙型肝炎的疗效预测指标探讨[J].中华肝脏病杂志, 2008, 16 (5) ∶341-344.
|
|
[9]谢冬英, 林炳亮, 徐启桓, 等.阿德福韦酯治疗e抗原阳性慢性乙型肝炎的疗效预测指标探讨[J].中华肝脏病杂志, 2008, 16 (5) ∶341-344.
|
|
[10]Locarnini S, Qi x, Arterburm S, et al.Incidence and predictors of e-mergence of adforir resistant HBV during4years of adeforir dipivoxil (ADV) therapy for patients with chronic hepatitis B (CHB) (abstr) [J].J Hepatol, 2005, 42 (supplz) ∶17.
|
|
[10]Locarnini S, Qi x, Arterburm S, et al.Incidence and predictors of e-mergence of adforir resistant HBV during4years of adeforir dipivoxil (ADV) therapy for patients with chronic hepatitis B (CHB) (abstr) [J].J Hepatol, 2005, 42 (supplz) ∶17.
|
|
[11]Westland CE, Yang H, Delaney WE4th, et al.Activity of adeforir dipivoxil against all patterns of lamivudine-resistant hepatitis B viru-ses in patients[J].J Viral Hepat, 2005, 12∶67-73.
|
|
[11]Westland CE, Yang H, Delaney WE4th, et al.Activity of adeforir dipivoxil against all patterns of lamivudine-resistant hepatitis B viru-ses in patients[J].J Viral Hepat, 2005, 12∶67-73.
|
|
[12]王笑梅, 兰孟东, 段英, 等.肝移植后乙型肝炎复发的临床表现与预后[J].胃肠病学和肝病学杂志, 2008, 17 (1) ∶55-58.
|
|
[12]王笑梅, 兰孟东, 段英, 等.肝移植后乙型肝炎复发的临床表现与预后[J].胃肠病学和肝病学杂志, 2008, 17 (1) ∶55-58.
|
|
[13]杨清, 龚作炯, 胡丹凤.阿德福韦酯和拉米夫定治疗乙型肝炎肝硬化失代偿期的临床观察[J].中华肝脏病杂志, 2007, 15 (11) ∶821-824.
|
|
[13]杨清, 龚作炯, 胡丹凤.阿德福韦酯和拉米夫定治疗乙型肝炎肝硬化失代偿期的临床观察[J].中华肝脏病杂志, 2007, 15 (11) ∶821-824.
|
|
[14]秦艳丽, 张继明, 黄五仙, 等.阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎患者的耐药率及耐药株进化情况[J].中华肝脏病杂志, 2007, 15 (1) ∶4-7.
|
|
[14]秦艳丽, 张继明, 黄五仙, 等.阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎患者的耐药率及耐药株进化情况[J].中华肝脏病杂志, 2007, 15 (1) ∶4-7.
|
|
[15]庄辉.对现行慢性乙型肝炎治疗的评价[J].中华肝脏病杂志, 2006, 14 (6) ∶402-405.
|
|
[15]庄辉.对现行慢性乙型肝炎治疗的评价[J].中华肝脏病杂志, 2006, 14 (6) ∶402-405.
|
|
[16]Lok AS, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2007, 45∶507-539.
|
|
[16]Lok AS, McMahon BJ.Chronic hepatitis B[J].Hepatology, 2007, 45∶507-539.
|
|
[17] 晓雯.摘译自APASL2008年会摘要:中国HBeAg阳性慢性乙型肝炎患者阿德福韦酯 (贺维力) 长期治疗研究[N].中国医学论坛报, 2008, 4.24D6.
|
|
[17] 晓雯.摘译自APASL2008年会摘要:中国HBeAg阳性慢性乙型肝炎患者阿德福韦酯 (贺维力) 长期治疗研究[N].中国医学论坛报, 2008, 4.24D6.
|
|
[18]Hadziyannis SJ, Tassopoulos NC, Heathcote E J, et al.long—term therapy with adeforir dipivoxil for HBeAg-negative chronic hepatitis B[J].N Engl J Med, 2005, 26∶2673-2681.
|
|
[18]Hadziyannis SJ, Tassopoulos NC, Heathcote E J, et al.long—term therapy with adeforir dipivoxil for HBeAg-negative chronic hepatitis B[J].N Engl J Med, 2005, 26∶2673-2681.
|
|
[19]Hadziyannis S, Tassopoulos NS, Chang TT, et al.long-term adeforir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B:results after5years of therapy[J].Hepatology, 2005, 42 (suppl1) ∶754A.
|
|
[19]Hadziyannis S, Tassopoulos NS, Chang TT, et al.long-term adeforir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B:results after5years of therapy[J].Hepatology, 2005, 42 (suppl1) ∶754A.
|
|
[20]Yeon J E, Yoo W, Hong SP, et al.Resistance to adeforir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adeforir dipivoxill[J].Cut, 2006, 55∶1488-1495.
|
|
[20]Yeon J E, Yoo W, Hong SP, et al.Resistance to adeforir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adeforir dipivoxill[J].Cut, 2006, 55∶1488-1495.
|
|
[21]Schildgen O, Sirma H, Funk A, et al.Variant of hepatitis B virus with primary resistance to adeforir[J].N Engl J Med, 2006, 354∶1807-1812.
|
|
[21]Schildgen O, Sirma H, Funk A, et al.Variant of hepatitis B virus with primary resistance to adeforir[J].N Engl J Med, 2006, 354∶1807-1812.
|
|
[22] 王宇明.亚太肝脏研究学会《慢性乙型肝炎治疗指南》2008版简介[N].中国医学论坛报, 2008, 4.10A8.
|
|
[22] 王宇明.亚太肝脏研究学会《慢性乙型肝炎治疗指南》2008版简介[N].中国医学论坛报, 2008, 4.10A8.
|
|
[23] 高志良.阿德福韦酯疗效欠佳的患者换用替比夫定治疗后可获得更多临床益处[J].中国医学论坛报2008, 34 (4) A8.
|
|
[23] 高志良.阿德福韦酯疗效欠佳的患者换用替比夫定治疗后可获得更多临床益处[J].中国医学论坛报2008, 34 (4) A8.
|
|
[24]茅益民, 曾民德.抗乙型病毒性肝炎新药-阿德福韦酯[J].中华肝脏杂志, 2004, 12 (1) ∶61-63.
|
|
[24]茅益民, 曾民德.抗乙型病毒性肝炎新药-阿德福韦酯[J].中华肝脏杂志, 2004, 12 (1) ∶61-63.
|
|
[25]Locarnin S, Qi X, Arterburn S, et al.Incidence and predictors of e-mergence of adeforir resistant HBV during for years of adeforir dipiv-oxil (ADV) therapy for patients with chronic hepatitis B (CHB) [J].J Hepatology, 2005, 42∶A17.
|
|
[25]Locarnin S, Qi X, Arterburn S, et al.Incidence and predictors of e-mergence of adeforir resistant HBV during for years of adeforir dipiv-oxil (ADV) therapy for patients with chronic hepatitis B (CHB) [J].J Hepatology, 2005, 42∶A17.
|
|
[26]韩伟, 刘宇琼, 孙雷.阿德福韦酯引起肾功能损害一例[J].肝脏, 2005, 10 (5) ∶290.
|
|
[26]韩伟, 刘宇琼, 孙雷.阿德福韦酯引起肾功能损害一例[J].肝脏, 2005, 10 (5) ∶290.
|
PDF下载 ( 131 KB)
本文二维码
下载:
